L&C Bio Co., Ltd (290650.KQ)
KRW 21050.0
(0.0%)
KRW 21050.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 68.86 Billion | 52.57 Billion | 45.67 Billion | 32.97 Billion | 29.15 Billion | 21.24 Billion |
| Cost of Revenue | 36.34 Billion | 25.58 Billion | 17.22 Billion | 13.41 Billion | 10.48 Billion | 7.85 Billion |
| Gross Profit | 32.52 Billion | 26.99 Billion | 28.45 Billion | 19.55 Billion | 18.66 Billion | 13.38 Billion |
| Operating Expenses | 25.86 Billion | 17.5 Billion | 15.28 Billion | 12.23 Billion | 9.63 Billion | 7.9 Billion |
| Selling, General and Administrative Expenses | 20.94 Billion | 9.42 Billion | 8.55 Billion | 7.23 Billion | 5.7 Billion | 4.76 Billion |
| Research and Development Expenses | 3.83 Billion | 2.19 Billion | 2.29 Billion | 2.38 Billion | 1.34 Billion | 1.26 Billion |
| Other Expenses | - | 232.31 Million | 302.65 Million | 22.3 Million | 56.57 Million | 16.55 Million |
| Cost and Expenses | 62.2 Billion | 43.08 Billion | 32.5 Billion | 25.64 Billion | 20.11 Billion | 15.76 Billion |
| Operating Income | 6.66 Billion | 9.48 Billion | 13.16 Billion | 7.32 Billion | 9.03 Billion | 5.47 Billion |
| Interest Expense | 6.19 Billion | 3.07 Billion | 460.26 Million | 743.24 Million | 60.55 Million | 18.04 Million |
| Income Tax Expense | 14.4 Billion | -1.12 Billion | 1.51 Billion | 795.5 Million | 1.46 Billion | 796.45 Million |
| Earnings before Tax | 62.93 Billion | 4.56 Billion | 17.09 Billion | 12.94 Billion | 9.92 Billion | 5.89 Billion |
| Net Income | 48.36 Billion | 4.54 Billion | 13.81 Billion | 10.81 Billion | 7.25 Billion | 5.2 Billion |
| Earnings Per Share Basic | 2096.33 | 200.32 | 619.55 | 493.83 | 331.03 | 276.67 |
| Earnings Per Share Diluted | 1956.17 | 200.32 | 619.55 | 493.83 | 330.03 | 271.00 |
| Weighted Average Shares Outstanding | 23.06 Million | 22.68 Million | 22.29 Million | 21.89 Million | 21.9 Million | 18.82 Million |
| Weighted Average Shares Outstanding (Diluted) | 24.72 Million | 22.68 Million | 22.29 Million | 21.89 Million | 21.96 Million | 19.21 Million |
| Gross Margin | 0.47 | 0.51 | 0.62 | 0.59 | 0.64 | 0.63 |
| EBIT Margin | 0.19 | 0.26 | 0.45 | 0.46 | 0.38 | 0.29 |
| Profit Margin | 0.70 | 0.09 | 0.30 | 0.33 | 0.25 | 0.25 |
| EBITDA | 13.4 Billion | 14.24 Billion | 16.07 Billion | 8.91 Billion | 10.11 Billion | 6.39 Billion |
| Earnings Before Tax Margin | 0.10 | 0.18 | 0.29 | 0.22 | 0.31 | 0.26 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 17.89 Billion | 16.56 Billion | 17.02 Billion | 68.86 Billion | 20.55 Billion | 16.48 Billion |
| Cost of Revenue | 9.29 Billion | 8.91 Billion | 10.25 Billion | 36.34 Billion | 8.77 Billion | 8.41 Billion |
| Gross Profit | 8.6 Billion | 7.64 Billion | 6.77 Billion | 32.52 Billion | 11.78 Billion | 8.07 Billion |
| Operating Expenses | 7.58 Billion | 6 Billion | 7.73 Billion | 25.86 Billion | 7.03 Billion | 6.46 Billion |
| Selling, General and Administrative Expenses | 6.25 Billion | 5.02 Billion | 6.35 Billion | - | 7.03 Billion | 6.46 Billion |
| Research and Development Expenses | 1.32 Billion | 974.46 Million | 1.38 Billion | - | 1.02 Billion | 1.47 Billion |
| Other Expenses | -7.91 Billion | 45.25 Million | 151.8 Million | 200.4 Million | 36.1 Million | 1.49 Million |
| Cost and Expenses | 16.88 Billion | 14.91 Billion | 17.98 Billion | 62.2 Billion | 15.8 Billion | 14.87 Billion |
| Operating Income | 1.01 Billion | 1.64 Billion | -962.24 Million | 6.66 Billion | 4.75 Billion | 1.61 Billion |
| Interest Expense | 2.07 Billion | 1.35 Billion | 2.85 Billion | 6.19 Billion | 1.67 Billion | 1.78 Billion |
| Income Tax Expense | 404.95 Million | 133.43 Million | -759.84 Million | 14.4 Billion | 15.14 Billion | -3.67 Million |
| Earnings before Tax | 2.34 Billion | 2 Billion | -2.17 Billion | 2.62 Billion | 64.51 Billion | 1.4 Billion |
| Net Income | 1.06 Billion | 1.55 Billion | -3.4 Billion | 48.36 Billion | 49.79 Billion | 1.37 Billion |
| Earnings Per Share Basic | 46.95 | 68.41 | -150.16 | - | 2195.17 | 60.41 |
| Earnings Per Share Diluted | 46.95 | 68.41 | -150.16 | - | 2195.17 | 60.41 |
| Weighted Average Shares Outstanding | 22.68 Million | 22.68 Million | 22.68 Million | 22.68 Million | 22.68 Million | 22.68 Million |
| Weighted Average Shares Outstanding (Diluted) | 22.68 Million | 22.68 Million | 22.68 Million | 24.72 Million | 22.68 Million | 22.68 Million |
| Gross Margin | 0.48 | 0.46 | 0.40 | 0.47 | 0.57 | 0.49 |
| EBIT Margin | 0.15 | 0.19 | 0.13 | - | 0.23 | 0.10 |
| Profit Margin | 0.06 | 0.09 | -0.20 | 0.70 | 2.42 | 0.08 |
| EBITDA | 2.6 Billion | 3.11 Billion | 2.19 Billion | - | 4.75 Billion | 1.61 Billion |
| Earnings Before Tax Margin | 0.06 | 0.10 | -0.06 | 0.10 | 0.23 | 0.10 |
OCAX
FNRC
002976
CLN
ENTRINT
JETAIRWAYS